Skip to main content
OpenTrials

Clinical trial condition

Fabry Disease

Explore clinical trials studying Fabry Disease. Study availability and eligibility vary by location and protocol.

175 public trials 38 recruiting studies
Refine in advanced search Browse all conditions

Fabry Disease trial results

Completed

A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease

NCT00074971

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California San Fransisco San Francisco, California, United States
  • Northwest Oncology & Hematology Associates Coral Springs, Florida, United States
  • Children's Memorial Hospital Chicago, Illinois, United States
View all 20 locations
View Trial Details
Completed

The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study

NCT00446862

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +29 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Emory University Atlanta, Georgia, United States
  • Feinberg School of Medicine, Northwestern University Chicago, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Completed

Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease

NCT01182818

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +23 more
Locations
  • Department of Neurology, Kreiskrankenhaus Altenburg Altenburg, Germany
  • Dept. of Neurology, Vivantes Netzwerk für Gesundheit GmbH, Klinikum Neukölln Berlin, Germany
  • Department of Neurology, Allgemeines Krankenhaus Celle Celle, Germany
  • Department of Neurology, Klinikum Chemnitz gGmbH Chemnitz, Germany
View all 14 locations
View Trial Details

Related conditions